{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:46:46Z","timestamp":1791877606707,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018512","name":"University of Hradec Kralove","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.tox.2026.154613","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:01:19Z","timestamp":1791561679000},"page":"154613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Digital twins in toxicology: Toward predictive, personalized and real-time risk assessment"],"prefix":"10.1016","volume":"528","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-1109","authenticated-orcid":false,"given":"Kamil","family":"Kuca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4883-0516","authenticated-orcid":false,"given":"Dominik","family":"Palla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0003-899X","authenticated-orcid":false,"given":"Jiri","family":"Krenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie","family":"Nepovimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2026.154613_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2026.113189","article-title":"Digital twin-enabled toxicology: current applications, opportunities, and future directions","volume":"425","author":"Adekunle","year":"2026","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2026.154613_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2023.107727","article-title":"Credibility assessment of computational models according to ASME V&V40: application to the bologna biomechanical computed tomography solution","volume":"240","author":"Aldieri","year":"2023","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.tox.2026.154613_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/psp4.12063","article-title":"Efficient generation and selection of virtual populations in quantitative systems pharmacology models","volume":"5","author":"Allen","year":"2016","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.tox.2026.154613_bib4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.tox.2026.154613_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/toxsci\/kfaa048","article-title":"A next-generation risk assessment case study for coumarin in cosmetic products","volume":"176","author":"Baltazar","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2026.154613_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41558-021-00986-y","article-title":"A digital twin of Earth for the green transition","volume":"11","author":"Bauer","year":"2021","journal-title":"Nat. Clim. Chang."},{"key":"10.1016\/j.tox.2026.154613_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13073-019-0701-3","article-title":"Digital twins to personalize medicine","volume":"12","author":"Bj\u00f6rnsson","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.tox.2026.154613_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tox.2010.06.007","article-title":"PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals","volume":"278","author":"Bois","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2026.154613_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fgene.2018.00031","article-title":"Digital twins in health care: ethical implications of an emerging engineering paradigm","volume":"9","author":"Bruynseels","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.tox.2026.154613_bib10","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR modeling: where have you been? Where are you going to?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2026.154613_bib11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2026.154613_bib12","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1021\/acs.est.6b06230","article-title":"Quantitative adverse outcome pathways and their application to predictive toxicology","volume":"51","author":"Conolly","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tox.2026.154613_bib13","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1093\/eurheartj\/ehaa159","article-title":"The \"digital twin\" to enable the vision of precision cardiology","volume":"41","author":"Corral-Acero","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tox.2026.154613_bib14","doi-asserted-by":"crossref","first-page":"30055","DOI":"10.1073\/pnas.1912789117","article-title":"The frontier of simulation-based inference","volume":"117","author":"Cranmer","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tox.2026.154613_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.comtox.2018.06.001","article-title":"Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients","volume":"7","author":"Dent","year":"2018","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2026.104637","article-title":"Digital twin approaches for interpretable side effect prediction in drug discovery","volume":"31","author":"Ecker","year":"2026","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.tox.2026.154613_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105269","article-title":"Integrate mechanistic evidence from new approach methodologies (NAMs) into a read-across assessment to characterise trends in shared mode of action","volume":"79","author":"Escher","year":"2022","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2026.154613_bib18","unstructured":"European Chemicals Agency (2026) Alternatives to animal testing under REACH. ECHA, Helsinki. https:\/\/echa.europa.eu\/animal-testing-under-reach. Accessed 7 September 2026."},{"key":"10.1016\/j.tox.2026.154613_bib19","unstructured":"European Medicines Agency (2024) Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle. EMA\/CHMP\/CVMP\/83833\/2023. https:\/\/www.ema.europa.eu\/en\/use-artificial-intelligence-ai-medicinal-product-lifecycle."},{"key":"10.1016\/j.tox.2026.154613_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/psp4.70229","article-title":"What is a digital twin in QSP and are we doing it right?","volume":"15","author":"Feigelman","year":"2026","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.tox.2026.154613_bib21","series-title":"Physiologically based pharmacokinetic analyses - format and content: guidance for industry. August 2018","author":"Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.tox.2026.154613_bib22","series-title":"Roadmap to reducing animal testing in preclinical safety studies","author":"Food and Drug Administration","year":"2025"},{"key":"10.1016\/j.tox.2026.154613_bib23","series-title":"Draft guidance for industry and Food and Drug Administration staff","article-title":"Artificial intelligence-enabled device software functions: lifecycle management and marketing submission recommendations","author":"Food and Drug Administration","year":"2025"},{"key":"10.1016\/j.tox.2026.154613_bib24","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3390\/ijms20051222","article-title":"Novichoks: the dangerous fourth generation of chemical weapons","volume":"20","author":"Franca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2026.154613_bib25","article-title":"The digital twin paradigm for future NASA and U.S. Air Force vehicles","author":"Glaessgen","year":"2012","journal-title":"53rd AIAA\/ASME\/ASCE\/AHS\/ASC Struct. Struct. Dyn. Mater. Conf."},{"key":"10.1016\/j.tox.2026.154613_bib26","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/jcm15031210","article-title":"From population-based PBPK to individualized virtual twins: clinical validation and applications in medicine","volume":"15","author":"Gon\u00e7alves","year":"2026","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tox.2026.154613_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0030189","article-title":"Universally sloppy parameter sensitivities in systems biology models","volume":"3","author":"Gutenkunst","year":"2007","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.tox.2026.154613_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/toxsci\/kfab009","article-title":"High-throughput transcriptomics platform for screening environmental chemicals","volume":"181","author":"Harrill","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2026.154613_bib29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/460208a","article-title":"Toxicology for the twenty-first century","volume":"460","author":"Hartung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.tox.2026.154613_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425255.2017.1246535","article-title":"Utility of the adverse outcome pathway concept in drug development","volume":"13","author":"Hartung","year":"2017","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib31","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/icb\/icab188","article-title":"Artificial intelligence for biology","volume":"61","author":"Hassoun","year":"2021","journal-title":"Integr. Comp. Biol."},{"key":"10.1016\/j.tox.2026.154613_bib32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41746-025-01897-4","article-title":"A consensus statement on the use of digital twins in medicine","volume":"8","author":"Iqbal","year":"2025","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.tox.2026.154613_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.41","article-title":"Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development","volume":"2","author":"Jones","year":"2013","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.tox.2026.154613_bib34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/jpm11080745","article-title":"Digital twins: from personalised medicine to precision public health","volume":"11","author":"Kamel Boulos","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.tox.2026.154613_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: a scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.tox.2026.154613_bib36","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1069492","article-title":"Systems biology: a brief overview","volume":"295","author":"Kitano","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.tox.2026.154613_bib37","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/etc.4125","article-title":"Adverse outcome pathway networks I: development and applications","volume":"37","author":"Knapen","year":"2018","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.tox.2026.154613_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-019-02613-4","article-title":"Toxicity testing in the 21st century: progress in the past decade and future perspectives","volume":"94","author":"Krewski","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40360-018-0196-3","article-title":"A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase","volume":"19","author":"Kuca","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","article-title":"Organs-on-chips: into the next decade","volume":"20","author":"Low","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.tox.2026.154613_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40572-025-00514-6","article-title":"Navigating the AI frontier in toxicology: trends, trust and transformation","volume":"12","author":"Luechtefeld","year":"2025","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.tox.2026.154613_bib42","doi-asserted-by":"crossref","DOI":"10.14573\/altex.2001241","article-title":"Biology-inspired microphysiological systems to advance medicines for patient benefit and animal welfare","author":"Marx","year":"2020","journal-title":"ALTEX 37365-394"},{"key":"10.1016\/j.tox.2026.154613_bib43","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/psp4.12669","article-title":"Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: building model credibility","volume":"10","author":"Musuamba","year":"2021","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.tox.2026.154613_bib44","series-title":"Toxicity testing in the 21st century: a vision and a strategy","author":"National Research Council","year":"2007"},{"key":"10.1016\/j.tox.2026.154613_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s43588-021-00072-5","article-title":"Scaling digital twins from the artisanal to the industrial","volume":"1","author":"Niederer","year":"2021","journal-title":"Nat. Comput. Sci."},{"key":"10.1016\/j.tox.2026.154613_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.comtox.2018.11.002","article-title":"Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making","volume":"9","author":"Paini","year":"2019","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fphys.2018.00106","article-title":"Validation and trustworthiness of multiscale models of cardiac electrophysiology","volume":"9","author":"Pathmanathan","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tox.2026.154613_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.tox.2026.154613_bib49","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/etc.4505","article-title":"Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment","volume":"38","author":"Perkins","year":"2019","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.tox.2026.154613_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/wcms.1240","article-title":"silico toxicology: computational methods for the prediction of chemical toxicity","volume":"6","author":"Raies","year":"2016","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.tox.2026.154613_bib51","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00204-022-03316-z","article-title":"Are the current commercially available oximes capable of reactivating acetylcholinesterase inhibited by the nerve agents of the A-series?","volume":"96","author":"Santos","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41746-025-01447-y","article-title":"Survey and perspective on verification, validation, and uncertainty quantification of digital twins for precision medicine","volume":"8","author":"Sel","year":"2025","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.tox.2026.154613_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41746-024-01146-0","article-title":"The effectiveness of digital twins in promoting precision health across the entire population: a systematic review","volume":"7","author":"Shen","year":"2024","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.tox.2026.154613_bib54","series-title":"Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms","author":"Sorger","year":"2011"},{"key":"10.1016\/j.tox.2026.154613_bib55","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00204-020-02774-7","article-title":"Quantitative adverse outcome pathway (qAOP) models for toxicity prediction","volume":"94","author":"Spinu","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2021.100206","article-title":"Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network","volume":"21","author":"Spinu","year":"2022","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib57","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/tx400410s","article-title":"Systems toxicology: from basic research to risk assessment","volume":"27","author":"Sturla","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib58","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1007\/s00170-017-0233-1","article-title":"Digital twin-driven product design, manufacturing and service with big data","volume":"94","author":"Tao","year":"2018","journal-title":"Int. J. Adv. Manuf. Technol."},{"key":"10.1016\/j.tox.2026.154613_bib59","article-title":"Federated machine learning in healthcare: a systematic review on clinical applications and technical architecture","volume":"5","author":"Teo","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.tox.2026.154613_bib60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2026.154613_bib61","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41746-025-01910-w","article-title":"A scoping review of human digital twins in healthcare applications and usage patterns","volume":"8","author":"Tudor","year":"2025","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.tox.2026.154613_bib62","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00204-022-03365-4","article-title":"A framework for establishing scientific confidence in new approach methodologies","volume":"96","author":"van der Zalm","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.18203\/2349-3259.ijct20161408","article-title":"silico clinical trials: how computer simulation will transform the biomedical industry","volume":"3","author":"Viceconti","year":"2016","journal-title":"Int. J. Clin. Trials"},{"key":"10.1016\/j.tox.2026.154613_bib64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ymeth.2020.01.011","article-title":"silico trials: verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products","volume":"185","author":"Viceconti","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.tox.2026.154613_bib65","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/etc.4124","article-title":"Adverse outcome pathway networks II: network analytics","volume":"37","author":"Villeneuve","year":"2018","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.tox.2026.154613_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41746-024-01188-4","article-title":"From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling","volume":"7","author":"Wang","year":"2024","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.tox.2026.154613_bib67","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.tox.2026.154613_bib68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cotox.2020.06.003","article-title":"DILIsym: quantitative systems toxicology impacting drug development","volume":"23-24","author":"Watkins","year":"2020","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.tox.2026.154613_bib69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tox.2014.05.012","article-title":"Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment","volume":"332","author":"Wetmore","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2026.154613_bib70","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41591-019-0548-6","article-title":"Do no harm: a roadmap for responsible machine learning for health care","volume":"25","author":"Wiens","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2026.154613_bib71","doi-asserted-by":"crossref","DOI":"10.1063\/5.0086789","article-title":"Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology","volume":"3","author":"Wu","year":"2022","journal-title":"Biophys. Rev."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X26002209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X26002209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:00:55Z","timestamp":1791874855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X26002209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":71,"alternative-id":["S0300483X26002209"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2026.154613","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digital twins in toxicology: Toward predictive, personalized and real-time risk assessment","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2026.154613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154613"}}